Newsroom
Anthony Hickey, Ph.D., an expert in aerosol and nanomaterials engineering at RTI International, received the Thomas T. Mercer Joint Prize from the American Association for Aerosol Research and International Society for Aerosols in Medicine.
The award recognizes Hickey for his achievements and groundbreaking research in the field of inhalable materials and pharmaceutical aerosols, including drugs and vaccines delivered by inhalers. His work has paved the way for new methods of treatment and prevention of asthma, cystic fibrosis, diabetes, tuberculosis and more.
The award honors the legacy of Thomas T. Mercer, a researcher and author whose research spanned aerosol physics and chemistry as well as inhalation toxicology, industrial hygiene and health physics.
Hickey has more than 30 years of academic and research experience in pulmonary biology, aerosol physics, powder dynamics, pharmacokinetics and drug disposition, formulation design and device development. He holds 22 patents and currently serves as a Distinguished Fellow at RTI and professor emeritus at the Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill.
RTI International is an independent, scientific research institute dedicated to improving the human condition. Our vision is to address the world's most critical problems with technical and science-based solutions in pursuit of a better future. Clients rely on us to answer questions that demand an objective and multidisciplinary approach—one that integrates expertise across social, statistical, data, and laboratory sciences, engineering, and other technical disciplines to solve the world’s most challenging problems.
For more information, visit www.rti.org.